Mirion’s Orders Jump 42% with Nuclear Power Fueling Record Growth: 2026 Outlook Reaffirmed
Market Chameleon (Wed, 29-Apr 4:26 AM ET)
Mirion Announces First Quarter 2026 Financial Results
Business Wire (Tue, 28-Apr 4:15 PM ET)
Mirion Announces Earnings Release and Conference Call Date for First Quarter 2026
Business Wire (Thu, 16-Apr 8:15 AM ET)
Mirion’s Nuclear Focus Drives Strong Q3 Results and $65 Million in Major Orders
Market Chameleon (Wed, 29-Oct 5:23 AM ET)
Mirion’s Upsized $356.2M Equity Offering Highlights Major Growth and Acquisition Plans
Market Chameleon (Fri, 26-Sep 6:41 AM ET)
Mirion Technologies Inc provides products, services, and software that allow customers to safely leverage the power of ionizing radiation for applications that benefit the health, safety, vitality, and technological progress of the human experience. The Company manages its operations through two segments: Nuclear & Safety and Medical. The Medical segment improves the quality and safety of cancer care delivery and supports applications across medical diagnostics and practitioner safety. The Nuclear & Safety segment powers advancements in nuclear energy and critical radiation safety, measurement and analysis applications across laboratories, research and other industrial markets such as defense.
Mirion Technologies Class A trades on the NYSE stock market under the symbol MIR.
As of June 10, 2026, MIR stock price declined to $15.82 with 3,079,152 million shares trading.
MIR has a beta of 1.75, meaning it tends to be more sensitive to market movements. MIR has a correlation of 0.28 to the broad based SPY ETF.
MIR has a market cap of $3.87 billion. This is considered a Mid Cap stock.
Last quarter Mirion Technologies Class A reported $258 million in Revenue and $.10 earnings per share. This beat revenue expectation by $12 million and exceeded earnings estimates by $.01.
In the last 3 years, MIR traded as high as $30.28 and as low as $6.70.
The top ETF exchange traded funds that MIR belongs to (by Net Assets): IJR, VTI, VB, VGT, IWM.
MIR has underperformed the market in the last year with a price return of -22.8% while the SPY ETF gained +22.2%. MIR has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -26.1% and -12.1%, respectively, while the SPY returned +7.2% and -3.4%, respectively.
MIR support price is $16.46 and resistance is $17.54 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that MIR shares will trade within this expected range on the day.
